Belpointe Asset Management’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-459	Closed	-$103K	–	3254
2023 Q1	$103K	Buy	459 +164	+56%	+$36.7K	0.01%	1289
2022 Q4	$82K	Buy	+295	New	+$82K	0.01%	1346